Hui‐Ming Lin

2.1k total citations
97 papers, 1.5k citations indexed

About

Hui‐Ming Lin is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui‐Ming Lin has authored 97 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 34 papers in Surgery and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui‐Ming Lin's work include Colorectal Cancer Surgical Treatments (28 papers), Colorectal and Anal Carcinomas (24 papers) and Prostate Cancer Treatment and Research (15 papers). Hui‐Ming Lin is often cited by papers focused on Colorectal Cancer Surgical Treatments (28 papers), Colorectal and Anal Carcinomas (24 papers) and Prostate Cancer Treatment and Research (15 papers). Hui‐Ming Lin collaborates with scholars based in China, Australia and United States. Hui‐Ming Lin's co-authors include Pan Chi, Xingrong Lu, Lisa G. Horvath, Daryl D. Rowan, Juliet A. Gerrard, Yanwu Sun, Ying Huang, Lynnette R. Ferguson, Nuala A. Helsby and Felicia M. Low and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cell Metabolism.

In The Last Decade

Hui‐Ming Lin

92 papers receiving 1.4k citations

Peers

Hui‐Ming Lin
Nan Jiang China
Edit Mikó Hungary
Bin Qiu China
Sharad Khare United States
Jing Kong China
Nan Jiang China
Hui‐Ming Lin
Citations per year, relative to Hui‐Ming Lin Hui‐Ming Lin (= 1×) peers Nan Jiang

Countries citing papers authored by Hui‐Ming Lin

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ming Lin more than expected).

Fields of papers citing papers by Hui‐Ming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ming Lin. The network helps show where Hui‐Ming Lin may publish in the future.

Co-authorship network of co-authors of Hui‐Ming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ming Lin. A scholar is included among the top collaborators of Hui‐Ming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ming Lin. Hui‐Ming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Hui‐Ming, Shuo Liu, Dong Liu, et al.. (2024). Sensing steroid hormone 17α-hydroxypregnenolone by GPR56 enables protection from ferroptosis-induced liver injury. Cell Metabolism. 36(11). 2402–2418.e10. 18 indexed citations
2.
Li, Jiaxin, et al.. (2024). Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets. International Journal of Biological Sciences. 21(2). 544–564. 3 indexed citations
3.
Lin, Hui‐Ming, Margaret M. Centenera, Kevin Huynh, et al.. (2024). Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer. JCO Precision Oncology. 8(8). e2400260–e2400260. 5 indexed citations
4.
Li, Tiffany, Hui‐Ming Lin, Hannah C. Timmins, et al.. (2024). Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy. JCO Precision Oncology. 8(8). e2300690–e2300690. 1 indexed citations
5.
Mahon, Kate, Hui‐Ming Lin, Martin R. Stockler, et al.. (2024). Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer. The Prostate. 84(8). 747–755. 5 indexed citations
6.
Ye, Xiang‐Yang, Hui‐Ming Lin, Shuo Lin, et al.. (2023). Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers. Journal of Medical Virology. 95(7). e28943–e28943. 2 indexed citations
7.
Zhe, Shandian, Hui‐Ming Lin, Arun Azad, et al.. (2023). Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer. JCO Clinical Cancer Informatics. 7(7). e2300057–e2300057. 3 indexed citations
8.
Liu, Zhun, Zhifen Chen, Xiaojie Wang, et al.. (2023). Pathways of lymph node metastasis and prognosis after right hemicolectomy for cecal cancer: results from a retrospective single center. World Journal of Surgical Oncology. 21(1). 281–281. 1 indexed citations
9.
Lin, Hui‐Ming, Thy Duong, Kate Mahon, et al.. (2022). Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin. Cancers. 14(19). 4792–4792. 8 indexed citations
10.
Christopoulos, Petros, S-H.I. Ou, Jianchang Lin, et al.. (2021). 1224P Systematic review and meta-analysis of immunotherapy effectiveness for pretreated patients with non-small cell lung cancer harboring EGFR exon 20 insertions. Annals of Oncology. 32. S972–S972. 2 indexed citations
11.
Lin, Yu, Yanwu Sun, Hui‐Ming Lin, et al.. (2021). Prediction of prolonged resolution of chylous ascites after radical D3 resection for colorectal cancer: A population-based experience from a high-volume center. European Journal of Surgical Oncology. 48(1). 204–210. 2 indexed citations
13.
Lin, Hui‐Ming, Kate Mahon, Jacquelyn M. Weir, et al.. (2017). A distinct plasma lipid signature associated with poor prognosis in castration‐resistant prostate cancer. International Journal of Cancer. 141(10). 2112–2120. 63 indexed citations
14.
Wang, Xiaojie, Pan Chi, Hui‐Ming Lin, et al.. (2017). Risk Factors for Early Postoperative Small Bowel Obstruction after Elective Colon Cancer Surgery: An Observational Study of 1,244 Consecutive Patients. Digestive Surgery. 35(1). 49–54. 13 indexed citations
15.
Lin, Hui‐Ming, Kate Mahon, Howard Gurney, et al.. (2017). Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer. British Journal of Cancer. 116(8). 1002–1011. 48 indexed citations
17.
Lee, Brian Y., Falko Hochgräfe, Hui‐Ming Lin, et al.. (2013). Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 13(1). 190–201. 41 indexed citations
18.
Lu, Xingrong, Jie Pan, Shaotang Li, et al.. (2013). Establishment of a Predictive Genetic Model for Estimating Chemotherapy Sensitivity of Colorectal Cancer with Synchronous Liver Metastasis. Cancer Biotherapy and Radiopharmaceuticals. 28(7). 552–558. 17 indexed citations
19.
Otter, Don, Mingshu Cao, Hui‐Ming Lin, et al.. (2010). Identification of Urinary Biomarkers of Colon Inflammation in IL10-/- Mice Using Short‐Column LCMS Metabolomics. BioMed Research International. 2011(1). 974701–974701. 21 indexed citations
20.
Lin, Hui‐Ming, Nuala A. Helsby, Daryl D. Rowan, & Lynnette R. Ferguson. (2010). Using metabolomic analysis to understand inflammatory bowel diseases. Inflammatory Bowel Diseases. 17(4). 1021–1029. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026